Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 30Central Nervous System Neoplasms 18Rectal Neoplasms 15Colorectal Neoplasms 15Lung Neoplasms 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Gliosarcoma 7Neoplasm Metastasis 6Esophageal Neoplasms 6Brain Neoplasms 6Adenocarcinoma Of Esophagus 6Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 5Breast Carcinoma In Situ 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Mesothelioma, Malignant 4Kidney Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Solitary Fibrous Tumor, Pleural 3Prostatic Neoplasms 3Ovarian Neoplasms 3

Interventions

Carboplatin 7Pemetrexed 6osimertinib 5Drug Therapy 5aflutinib 4tislelizumab 3anlotinib 3Radiotherapy 3Radiosurgery 3Paclitaxel 3Cisplatin 3toripalimab 2pembrolizumab 2camrelizumab 2apatinib 2Surgical Procedures, Operative 2S 1 (combination) 2HM781-36B 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2trilaciclib 1surufatinib 1sintilimab 1rezivertinib 1lenvatinib 1icotinib 1famitinib 1envafolimab 1dacomitinib 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × NSCLC × Chemotherapy, Adjuvant × Clear all
NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
34 enrolled
Thoracic

NSCLC

NCT05286957 2023-03-17

Seagull

The First Affiliated Hospital of Zhengzhou University

Phase 2 Recruiting
60 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡